People · Operator
Named in public records as an officer, director or promoter · active 2009–2019 · Medical Devices, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Celsee Diagnostics, Inc. | — | Medical Devices | Series B | $40.5M | $135.3M | 2019 |
| Novelix Pharmaceuticals Inc | — | Pharmaceuticals | Pre-Seed | $253K | $12.0M | 2009 |
Timothy Triche at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Timothy Triche on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Miller | 1 | 27 |
| Jack Ball | 1 | 10 |
| Gregg Fergus | 1 | 5 |
| Tim Mayleben | 1 | 4 |
| Roger Newton | 1 | 4 |
| TIMOTHY MAYLEBEN | 1 | 3 |
| Walter Young, Jr. | 1 | 2 |
| Kalyan Handique | 1 | 2 |
| Priyadarshini Gogoi | 1 | 2 |
| Burkhard Jansen | 1 | 2 |
| Jeremy Teraoka | 1 | 1 |
| Priyardarshini Gogoi | 1 | 1 |
| John Stark | 1 | 1 |
| Richard Sharp | 1 | 1 |
| Dr. David Parkinson | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.